HomeBiotech

Biotech

Anavex Life Sciences (AVXL) Upgraded to Buy: Here’s Why

Anavex Life Sciences (AVXL) Upgraded to Buy: Here’s Why

December 31, 2020

FBIO Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Fortress Biotech, Inc. Investors of Class Action and Lead Plaintiff Deadline: January 26, 2021

FBIO Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Fortress Biotech, Inc. Investors of Class Action and Lead Plaintiff Deadline: January 26, 2021

December 31, 2020

Altimmune (ALT) Begins Phase II Study for Chronic Hepatitis B

Altimmune (ALT) Begins Phase II Study for Chronic Hepatitis B

December 31, 2020

Arcturus (ARCT) to Develop ARCT-032 for Cystic Fibrosis

Arcturus (ARCT) to Develop ARCT-032 for Cystic Fibrosis

December 31, 2020

SHAREHOLDER ALERT: WeissLaw LLP Reminds ANCN, PRVL, TLRY, and GNBF Shareholders About Its Ongoing Investigations

SHAREHOLDER ALERT: WeissLaw LLP Reminds ANCN, PRVL, TLRY, and GNBF Shareholders About Its Ongoing Investigations

December 30, 2020

Aeglea (AGLE) Upgraded to Buy: Here’s Why

Aeglea (AGLE) Upgraded to Buy: Here’s Why

December 30, 2020

Novo Nordisk (NVO) Files for Ozempic’s Label Expansion in EU

Novo Nordisk (NVO) Files for Ozempic’s Label Expansion in EU

December 30, 2020

SHAREHOLDER ACTION NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Fortress Biotech, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

SHAREHOLDER ACTION NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Fortress Biotech, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

December 30, 2020

New Strong Sell Stocks for December 30th

New Strong Sell Stocks for December 30th

December 30, 2020

Cyclacel Pharmaceuticals to Present at Biotech Showcase(TM) Digital 2021

Cyclacel Pharmaceuticals to Present at Biotech Showcase(TM) Digital 2021

December 30, 2020

« 1 … 670 671 672 673 674 … 692 »